Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia

NCT06392711 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Xerostomia
Graft-versus-host-disease
Sjogren's Disease

Interventions

BIOLOGICAL: Mesenchymal Stromal Cells (MSC) Dose Level 0
BIOLOGICAL: Mesenchymal Stromal Cells (MSC) Dose Level 1

Sponsor

University of Wisconsin, Madison